Find Academic Supervisors

Dr. Daniel R Obaid is a Clinical Associate Professor and Consultant Cardiologist at Swansea University Medical School , specializing in Biomedical Sciences . His clinical academic work at the Morriston Regional Cardiac Centre and ILS 2 Clinical Imaging Facility focuses on advanced cardiovascular imaging and interventional cardiology. Expertise in Interventional Cardiology , Cardiac CT , and Atherosclerotic Plaque Imaging Significant contributions to patient safety and human factors in cardiovascular procedures Recipient of the Young Investigator Prize from the Society of Cardiovascular CT, USA His research integrates invasive and non-invasive imaging techniques to identify vulnerable plaques, with publications spanning atherosclerosis , clot microstructure , and AI applications in cardiology . Current studies include virtual TAVR simulations and biomechanical analysis of plaque stress . Recent collaborative work explores low-dose radiation protocols , LDL transport modeling , and anti-inflammatory effects of GLP-1 agonists , reflecting interdisciplinary approaches to cardiovascular risk mitigation. Available for postgraduate supervision , Dr. Obaid has contributed to undergraduate medical professionalism and cardiovascular physiology modules (PM-241F, PM-266).

• Interventional Cardiology
• Cardiac Computed Tomography
• Intravascular Imaging
• +5 more

Dr. Mojtaba Lashgari is a Postdoctoral Research Fellow at the University of Oxford's Institute of Biomedical Engineering (IBME), part of the Department of Engineering Science. He joined in May 2023 under Dr. Abhirup Banerjee's group, focusing on developing AI-driven tools for real-time analysis of multimodal cardiac imaging data to enhance patient care in catheterization labs. His work includes automated identification of coronary blockages, blood flow assessment, and myocardial perfusion evaluation. He earned his PhD at the University of Leeds (2023) under Prof. Alejandro Frangi and Prof. Jürgen Schneider, funded by the EU Horizon 2020 program. His doctoral research developed an in-silico framework for microstructure-sensitive myocardial diffusion-weighted MRI, bridging computational modeling and medical imaging. Research Interests: Medical Image Computing, In-Silico Medicine, and Multimodal Medical Data Integration & Analysis (MultiMeDIA lab). His publications span AI-driven cardiac imaging, virtual imaging trials in MRI, and dental micro-CT denoising techniques. Grants & Funding: European Union’s Horizon 2020 program (PhD funding) Labs & Affiliations: MultiMeDIA Lab (led by Dr. Abhirup Banerjee), Institute of Biomedical Engineering (IBME).

• Medical Image Computing
• In-Silico Medicine
• Cardiac Imaging
• +3 more

Paul Rees is a Senior Lecturer in Military Medicine at the Blizard Institute (Faculty of Medicine and Dentistry), Queen Mary University of London. He works as Surgeon Commander providing clinical services at Barts Heart Centre , delivering 24-7 heart attack coverage across London. His military experience includes submarine medicine, front-line medical support in commando operations, and Afghanistan MERT consultancy. Military HEMS consultant at East Anglian Air Ambulance Co-founder of British Cardiac Intervention Society’s cardiac arrest group Lead for resuscitation services within Barts Health NHS Trust Research Interests: Focus on endovascular resuscitation, cadaveric intravascular ultrasound guidance, and selective aortic arch perfusion. Key applications in battlefield and austere environments. Teaching: Module Lead for MSc in Emergency and Resuscitation Medicine and MSc in Tactical, Military, Austere and Operational Medicine at QMUL. Contact: Email: cardiacexpert@nhs.net Phone: 020 3765 8639 Professional Profile: Dr. Paul Rees on Doctify

• Military Medicine
• Emergency Medicine
• Interventional Cardiology
• +3 more

Weiwei Cui is a Visiting Professor at the School of Electronic Engineering and Computer Science, Queen Mary University of London. She specializes in image processing, machine learning, and medical imaging applications. Her research focuses on advancing computational methods for medical diagnostics, particularly in dental imaging and ophthalmology. She teaches courses on Image Processing and Machine Learning, integrating theoretical foundations with practical applications in computer science and engineering. Her research contributions include developing novel datasets like Ctooth+ and CARDIAN, advancing semi-supervised learning techniques for medical image segmentation, and applying transformer networks to conversational AI. Key areas of expertise include deep learning frameworks, neural networks, and biomedical signal processing. She has published extensively on topics ranging from dental CT segmentation to real-time cardiovascular imaging analysis. Dr. Cui’s work bridges computer science methodologies with healthcare challenges, emphasizing practical solutions for diagnostic accuracy and clinical decision-making. Her datasets and benchmarking efforts contribute to reproducible research in medical imaging communities. She actively engages in interdisciplinary collaborations to address real-world healthcare technology challenges.

• Image Processing
• Machine Learning
• Medical Imaging
• +3 more

Krishnaraj Rathod is a Clinical Senior Lecturer at Queen Mary University of London's William Harvey Research Institute and a Consultant Interventional Cardiologist at Barts Heart Centre. His academic role combines clinical practice with translational cardiovascular research, focusing on nitrate therapy, reperfusion injury, and interventional cardiology outcomes. He holds a prestigious NIHR Doctoral Research Fellowship and leads the NITRATE-OCT clinical trial investigating dietary nitrate's effects in stable angina patients. Education: MBBS with distinctions from Barts School of Medicine, including an intercalated BMedSci (1st Class Hons) in Molecular Therapeutics. Completed an MSc in Clinical Trials and is actively supervising 4 PhD/MD students. Research Interests: Translational clinical trials, nitric oxide biochemistry, sex differences in cardiovascular disease, and cost-effectiveness of therapies. He has published over 110 peer-reviewed articles and 200 abstracts, with a focus on coronary artery disease, revascularization strategies, and post-PCI outcomes. Awards: Over 100 awards, including the British Cardiology Society 'Best of the Best' Abstract (2023), HSJ Innovation Award (2022), and BPS Vogt Prize (2019). Recognized for contributions to acute myocardial infarction pathway optimization and nitrate research. Teaching: Leads cardiology education at Queen Mary, supervises medical students, and co-directs interventional cardiology training programs. Actively involved in postgraduate research supervision and clinical mentorship. Labs/Teams: Principal investigator in the Vascular Pharmacology Group and Barts Interventional Cardiology Research Department, collaborating with Professors Ahluwalia, Mathur, and Baumbach on projects ranging from nitrate mechanisms to regenerative medicine.

• Cardiovascular Disease
• Clinical Trials
• Nitrate and Nitric Oxide Pathways
• +6 more

David Lines is a Knowledge Exchange Fellow in the Electronic and Electrical Engineering department within the Faculty of Engineering at the University of Strathclyde. His work focuses on advancing non-destructive evaluation technologies for industrial applications, particularly in ultrasonics and phased array systems. His research interests center on developing innovative ultrasonic inspection techniques for complex industrial components, eco-friendly transducer materials, and real-time monitoring systems for manufacturing processes. Key areas include resin infusion process monitoring in composite manufacturing, cladding integrity inspection, and intravascular ultrasound applications. His work bridges academic research with industrial implementation through multiple knowledge transfer partnerships. Lines has received significant recognition including the Roy Sharpe Prize (2022), National Instruments Global Engineering Impact Award (2019), and multiple BINDT awards. His research output demonstrates consistent contributions to NDE methodology development. As an active contributor to industrial projects, Lines serves as Principal Investigator or Research Co-investigator on multiple funded initiatives including KTP projects with National Oilwell Varco and Glasgow City Region innovation partnerships. His professional activities include frequent conference presentations and workshop participation in ultrasonics and NDE communities.

• Non-Destructive Testing
• Ultrasonics
• Phased Array Ultrasonic Testing
• +3 more

Professor Rob Krams is Chair of the Division of Bioengineering and Scientific Director of the CVDHub at Queen Mary University of London's School of Engineering and Materials Science. His research integrates engineering and molecular biology to study cardiovascular biomechanics, epigenetic regulation, and atherosclerosis. With over 500 publications, he focuses on mechanotransduction, shear stress effects on vascular biology, and advanced imaging techniques. Research Interests: His lab investigates how mechanical forces influence gene expression in endothelial cells using CRISPR, high-throughput screening, and fluid-structure interaction modeling. Key areas include non-coding RNA networks, synthetic biology approaches for vascular repair, and multi-scale computational models bridging cellular responses to hemodynamics. Publication Trends: Recent work emphasizes machine learning applications in hemodynamics, deep learning for plaque classification, and novel imaging techniques for shear stress quantification. His articles consistently explore intersections of computational modeling, molecular biology, and translational cardiology. Awards & Recognition: Established Investigator Award (2003–2008) Associate Editor for 12 scientific journals Research Infrastructure: Leads a multidisciplinary team at the Centre for Bioengineering, developing pipelines for in vivo endothelial cell isolation, RNA analysis, and CRISPR validation. Collaborates globally on projects involving intravascular imaging, animal models of atherosclerosis, and biomechanical diagnostics.

• Cardiovascular Disease
• Atherosclerosis
• Biomaterials
• +7 more

Andrew Farmery is a Professor of Anaesthetics at the University of Oxford , where he serves as Head of the Nuffield Division of Anaesthetics . He is also a Fellow & Tutor in Medicine at Wadham College , Oxford, overseeing undergraduate medical education. Research Interests : His work bridges biomedical engineering and respiratory physiology , focusing on developing intravascular sensors and analytical techniques to monitor respiratory and cardiovascular dysfunction in critically ill patients. Key projects include the Inspired Sinewave Technique (IST) , which quantifies lung heterogeneity , cardiac output , and ‘baby lung’ volume in ARDS and COPD models. He emphasizes translating these innovations into medical devices for improved patient care, supported by grants from the Wellcome Trust , EPSRC , and NIHR . Publications : His recent articles highlight the IST as a non-invasive tool for assessing lung injury , ventilation heterogeneity , and hemodynamic changes in animal models . Studies span ARDS , COPD , and PPE sustainability , reflecting interdisciplinary applications. Methodological works include computational simulations and CT validation for physiological modeling. Labs & Teams : He leads the Respiratory Physiology and Biomedical Engineering Group and is affiliated with the Ventilator Weaning and Extubation in Neurocritical Care Network , integrating clinical and engineering expertise.

• Biomedical Engineering
• Respiratory Physiology
• Critical Care Medicine
• +5 more

Adrian Banning is a Professor of Interventional Cardiology at the University of Oxford's Radcliffe Department of Medicine. His research focuses on mechanisms of myocardial injury during percutaneous coronary intervention (PCI), reperfusion in ST-elevation myocardial infarction (STEMI), and the clinical application of drug-eluting stents (DES) and intravascular ultrasound (IVUS). He has led landmark clinical trials such as the SYNTAX trial (comparing DES with coronary artery bypass grafting) and the HORIZONS trial (primary PCI in acute myocardial infarction). His work has influenced international guidelines for revascularization strategies and biochemical definitions of cardiac injury. Key contributions include advancing day-case PCI protocols, paramedic-delivered clopidogrel for AMI patients, and Oxford's region-wide Primary PCI service. He co-authored national guidelines for valvular heart disease management and leads projects on transcatheter aortic valve implantation (TAVI). Banning has an h-index of 43 and over 200 peer-reviewed publications, with recent work exploring cerebral embolic protection in TAVI and photon-counting CT angiography for coronary assessment. His clinical leadership roles include Principal Investigator for multiple international trials (e.g., TAXUS, SYNTAX) and recruitment success in pivotal studies like Excel (left main coronary disease trial). He has trained numerous interventional cardiologists and maintains active collaborations with industry and NHS services to improve cardiac care delivery and outcomes.

• Interventional Cardiology
• Cardiac Revascularization
• Myocardial Injury
• +3 more

Dr Muhammad Rashid is an NIHR Academic Clinical Lecturer in Cardiology at Keele University, affiliated with the School of Medicine. He holds a clinical role as an interventional cardiology specialist registrar at Royal Stoke University Hospital. His academic career includes a PhD in cardiovascular epidemiology (2019) and a focus on leveraging big data to improve cardiovascular care. Education: MBBS from Allama Iqbal Medical College (2007), followed by clinical training in the UK including core medical training at Royal Liverpool University Hospital. His research emphasizes real-world outcomes of cardiovascular interventions using datasets like MINAP and BCIS. Research interests include cardiovascular epidemiology, interventional cardiology techniques (e.g., PCI, TAVI), and health policy analysis. He has published extensively in top journals like Circulation and European Heart Journal, focusing on disparities in AMI care, outcomes of complex PCI, and cancer-cardiovascular interactions. Teaching roles include directing Mersey Medicine educational programs and co-supervising medical students. His clinical practice involves treating coronary artery disease and valvular heart conditions. He actively contributes to national registries and collaborates with NHS trusts in clinical education.

• Cardiovascular Epidemiology
• Cardiology
• Data Science in Healthcare
• +3 more

Professor Alex Rothman is a Professor of Cardiology at the University of Sheffield, affiliated with the School of Medicine and Population Health. He is an Honorary Consultant Cardiologist at Sheffield Teaching Hospitals NHS Trust and leads the Academic Unit of Primary Medical Care. His research focuses on pulmonary hypertension, heart failure, and translational medicine, emphasizing novel therapies and clinical trial methodologies. He holds academic qualifications including MA, BM BCh, MRes, PhD, MRCP, and EEGC. Education: Medical training at the University of Cambridge and University of Oxford MRes and PhD in cardiology-related research Research Interests: Pulmonary hypertension, heart failure, clinical trial design, remote patient monitoring, and therapeutic innovation . His work has led to regulatory-approved drugs/devices and focuses on personalized treatment strategies and implantable technologies for hemodynamic monitoring. Grants & Projects: MRC Experimental Medicine grant (£1.7m) for PHoenix trial EPSRC funding for cardiovascular digital twins (£10m) Innovate UK projects on remote monitoring systems (£999k total) Wellcome Trust and NIH-funded studies Awards: While no personal awards are explicitly listed, his team has received national/international accolades for research contributions. Labs/Teams: Leads a multidisciplinary group integrating clinical, translational, and engineering approaches to cardiovascular disease. Collaborates with industry partners and NHS systems for technology development and implementation.

• Cardiology
• Pulmonary Hypertension
• Heart Failure
• +3 more

Qianni Zhang is a Senior Lecturer and PhD/PDRA Engagement Lead at the Centre for Multimodal AI within the School of Electronic Engineering and Computer Science at Queen Mary University of London. She leads research initiatives at the intersection of artificial intelligence and healthcare applications, with a particular focus on medical image analysis. Dr. Zhang's research interests center on machine learning and computer vision with specific applications in medical image computing . Her work spans multiple domains including medical imaging analysis for cardiology, ophthalmology, and oncology. She has developed numerous deep learning approaches for image segmentation, registration, and analysis, particularly focused on intravascular ultrasound, optical coherence tomography, and MRI applications. Her research bridges theoretical computer vision with practical clinical needs, creating tools that have potential to improve diagnostic accuracy and treatment planning in healthcare settings. Her recent publications demonstrate a clear trajectory toward increasingly sophisticated multimodal AI approaches for medical imaging. The trend shows progression from basic image segmentation techniques to complex fusion networks that combine multiple imaging modalities and incorporate anatomical knowledge. Many of her papers focus on cardiovascular applications, particularly intravascular ultrasound analysis, while others address ophthalmological and general medical imaging challenges. The consistent theme across her work is the application of cutting-edge deep learning techniques to solve real-world medical imaging problems with clinical relevance. ARCNET (Barts and the London Charity, £15,496, 2025-2026) Deep Learning based Multispectral Image Analysis for Retinal Lesion Detection (Royal Society, £12,000, 2022-2025) Anatomical And Functional Analysis Of The Soft Palate (Barts Health NHS, £132,620, 2022-2025) Machine learning for improved graphics in sport broadcast (Innovate UK, £214,061, 2022-2024) Dr. Zhang supervises a diverse group of PhD students working on various aspects of medical image computing and multimodal AI. Her students' projects span multiple healthcare domains including cardiovascular imaging, ophthalmology, dentistry, and general medical diagnostics. She has established herself as a leading researcher in applying deep learning to medical imaging challenges, with particular expertise in segmentation, registration, and multimodal fusion techniques for clinical applications.

• Machine learning
• Computer vision
• Medical image computing
• +2 more

Dr. Shakil Awan is an Associate Professor in Electronics and Nanotechnology at the University of Plymouth , where he serves as Academic Lead for the Nanomaterials and Devices (NMD) Laboratory . He is a member of the Nanotechnology and Electronics Research Group and chairs the Electronics and Robotics External Advisory Panel . He has led the Electronics and Robotics Programme Refresh since 2022 and contributes to strategic academic reviews as part of the SECaM Engineering Portfolio Review Panel . Research Focus Graphene-based sensors for Alzheimer’s disease and hepatic cancer biomarker detection Electromagnetic properties of nanomaterials at DC, RF, and THz frequencies Development of precision resistance standards and LCR meter calibration techniques Integration of natural and synthetic nanomaterials in biosensing and environmental remediation Scientific Contributions His research spans graphene field-effect transistors , aptamer functionalization , and electromagnetic metrology , with a focus on biomedical diagnostics , environmental sensing , and quantum transport . Key trends include label-free detection of proteins and ions, high-frequency precision measurement , and sustainable nanomaterials for water purification. Teaching & Academic Leadership Module Leader for courses in Electrical Principles , Electronic Design , and Nanoelectronics since 2014 Supervisor for PhD and MSc students , including funded projects from EPSRC DTP , Zimmer & Peacock , and University of Plymouth Contributions to SECaM Portfolio Review and national metrology standards Labs & Collaborations Dr. Awan’s work is anchored at the Nanomaterials and Devices Laboratory , with collaborations at NPL , Imperial College London , and University of Cambridge . His projects emphasize healthcare applications , environmental monitoring , and electromagnetic standards .

• Nanotechnology
• Graphene Sensors
• Biosensors
• +5 more

Stephen Wheatcroft serves as Professor of Cardiometabolic Medicine at the University of Leeds' Faculty of Medicine and Health, where he holds dual leadership roles as Director of Research & Innovation for the School of Medicine and Head of the Discovery and Translational Science Department. An academic interventional cardiologist and vascular biologist, he leads research on insulin-like growth factor binding proteins in cardio-metabolic disease. His educational background includes: BSc (Hons) and MBChB (Hons) from University of Birmingham (1994) PhD in Cardiovascular Medicine from King's College London (2000-2003) Clinical cardiology training at King's College Hospital London Visiting fellowships at Charles University (Prague) and Jagiellonian University (Kraków) Wheatcroft's research spans basic vascular biology and clinical cardiology . His laboratory investigates insulin-like growth factor system mechanisms in endothelial function, atherosclerosis, and metabolic regulation, while his clinical work focuses on coronary physiology and acute coronary syndrome management. Recent publications reveal intensified exploration of endothelial-adipose tissue crosstalk , IGF receptor signaling , and translational interventions for diabetes complications and vascular disease. His group employs genetic models, human tissue studies, and clinical trial leadership to bridge molecular discoveries with patient care. Award highlights: British Atherosclerosis Society Michael Davies Young Investigator Award (2005) British Society for Cardiovascular Research Excellence Prize (2017) British Atherosclerosis Society John French Lecturer (2016) Fellowship of European Society of Cardiology (2016) As an educator, Wheatcroft supervises PhD/MD candidates and serves as academic representative for cardiology trainees. His research program, funded by British Heart Foundation, Diabetes UK, MRC, and ERC grants, drives discovery through the Leeds Institute of Cardiovascular and Metabolic Medicine and Multidisciplinary Cardiovascular Research Centre . Current initiatives include therapeutic angiogenesis projects and endothelial regeneration studies.

• Cardiometabolic Medicine
• Vascular Biology
• Atherosclerosis
• +7 more

Mohammed M Chowdhury serves as a National Institute of Health Research Academic Clinical Lecturer and British Heart Foundation Clinical Research Fellow in Vascular Surgery at the University of Cambridge's School of Clinical Medicine. His dual clinical-academic role includes being a Speciality Registrar in Vascular Surgery at Cambridge University Hospitals/NHS. His research activities are centered within the Cambridge Cardiovascular Interdisciplinary Research Centre, where he contributes to the BHF Cambridge Centre of Excellence and the NIHR Cambridge Biomedical Research Centre. Dr. Chowdhury's research program focuses on advancing molecular imaging techniques for vascular disease detection and monitoring. His work particularly emphasizes in vivo mechanisms of vascular disease with a strong focus on inflammation-based molecular imaging. Current projects investigate optoacoustic imaging applications in preclinical vascular disease and novel intravascular techniques for local therapies. His laboratory work spans multiple institutions, including collaborations with Harvard University's Farouc Jaffer and Guillermo Tearney labs and MIT's Langer Lab. Analysis of Dr. Chowdhury's recent publications reveals a strong emphasis on translational vascular imaging research, particularly the application of advanced imaging modalities like PET, MRI, and CT radiomics to characterize atherosclerotic plaque features. His work consistently bridges molecular mechanisms with clinical applications, focusing on identifying vulnerable plaques, predicting restenosis, and developing novel imaging biomarkers for vascular disease progression. His scientific achievements have been recognized through prestigious awards: Society of Academic and Research Surgery (Norman Williams Prize) American Heart Association (Jay D Coffman PVD Young Investigators Award) Vascular Society of Great Britain and Ireland (British Journal of Surgery Vascular President's Prize) Dr. Chowdhury has secured competitive funding from major organizations including the British Heart Foundation (Clinical Research Training Fellowship and Clinical Career Development Fellowship), Royal College of Surgeons of England Research Fellowship, and the Parke-Davies Travelling Fellowship. His research program demonstrates successful transition from trainee to independent investigator, with growing leadership in both clinical vascular surgery and cardiovascular research methodology. His laboratory work spans multiple prestigious institutions, including the Farouc Jaffer and Guillermo Tearney labs at Harvard University where he completed postdoctoral work, and the Langer Lab at MIT where he explored intravascular drug delivery techniques. At Cambridge, he contributes to the vibrant research environment of the Cambridge Cardiovascular Interdisciplinary Research Centre, collaborating with multiple principal investigators including Dr. Paul Hayes, Dr. Umar Sadat, Mr. Patrick Coughlin, and Professor James Rudd.

• Vascular Surgery
• Molecular Imaging
• Atherosclerosis
• +5 more